Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Paul H. Lange
Phase 1/2 Study of Preoperative Docetaxel and Mitoxantrone for High-Risk Prostate Cancer
Cancer
Cancer Research
Oncology
Androgenic Induction of Prostate-Specific Antigen Gene Is Repressed by Protein-Protein Interaction Between the Androgen Receptor and AP-1/c-Jun in the Human Prostate Cancer Cell Line LNCaP
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Related publications
Phase II Randomized Study of Figitumumab Plus Docetaxel and Docetaxel Alone With Crossover for Metastatic Castration-Resistant Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Optimising Preoperative Risk Stratification Tools for Prostate Cancer Using mpMRI
European Radiology
Medicine
Nuclear Medicine
Radiology
Imaging
Treatment of Hormone-Refractory Prostate Cancer With Docetaxel or Mitoxantrone: Relationships Between Prostate-Specific Antigen, Pain, and Quality of Life Response and Survival in the TAX-327 Study
Clinical Cancer Research
Cancer Research
Oncology
Successful Phase 2 Trial of Ultrafocal Brachytherapy for Low/Intermediate Risk Prostate Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Preoperative Androgen Deprivation Therapy for Localized Prostate Cancer: Delayed Biochemical Recurrence in High-Risk Disease
Clinical Genitourinary Cancer
Oncology
Urology
Sunitinib Plus Androgen Deprivation and Radiation Therapy for Patients With Localized High-Risk Prostate Cancer: Results From a Multi-Institutional Phase 1 Study
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
A Prospective Study of Socioeconomic Status, Prostate Cancer Screening and Incidence Among Men at High Risk for Prostate Cancer
Cancer Causes and Control
Cancer Research
Oncology
A Phase I Trial of Adenovector-Mediated Delivery of Interleukin-2 (AdIL-2) in High-Risk Localized Prostate Cancer
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Phase 1–2 Study of Docetaxel Plus Aflibercept in Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
The Lancet Oncology
Oncology
